Concepedia

Author

Ryo Tatsumi

Mitsubishi Chemical (Japan)

Also Known As

Ryo Tatsumi

10

Publications

190

Citations

7

H-Index

21

Concepts

All Affiliations

Mitsubishi Chemical (Japan)
RT

About

Ryo Tatsumi is an author at Mitsubishi Chemical (Japan) specializing in pharmacology, medicine, and neuropharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

126

2

Natural Sciences

2

2

89

3

Biochemistry

2

2

89

4

Engineering

1

1

17

5

Biomedical Engineering

1

1

17

Ryo Tatsumi

×

6

Publications

176

Citations

6

H-Index

YearCitations

Discovery of the α7 Nicotinic Acetylcholine Receptor Agonists. (<i>R</i>)-3‘-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5‘-[1‘,3‘]oxazolidin-2‘-one as a Novel, Potent, Selective, and Orally Bioavailable Ligand

Ryo Tatsumi, Masakazu Fujio, Hiroyuki Satoh,

Journal of Medicinal Chemistry

2005

46

(<i>R</i>)-3‘-(3-Methylbenzo[<i>b</i>]thiophen-5-yl)spiro[1-azabicyclo[2,2,2]octane-3,5‘-oxazolidin]-2‘-one, a Novel and Potent α7 Nicotinic Acetylcholine Receptor Partial Agonist Displays Cognitive Enhancing Properties

Ryo Tatsumi, Masakazu Fujio, Shin-ichi Takanashi,

Journal of Medicinal Chemistry

2006

43

A new route for the construction of the AB-ring core of Taxol

Yumi Shimada, Makoto Nakamura, Toshimasa Suzuka,

Tetrahedron Letters

2003

25

(+)-3-[2-(Benzo[b]thiophen-2-yl)-2-oxoethyl]-1-azabicyclo[2.2.2]octane as potent agonists for the α7 nicotinic acetylcholine receptor

Ryo Tatsumi, Kohji Seio, Masakazu Fujio,

Bioorganic & Medicinal Chemistry Letters

2004

25

Synthesis and evaluation of [125I]I-TSA as a brain nicotinic acetylcholine receptor α7 subtype imaging agent

Mikako Ogawa, Ryo Tatsumi, Masakazu Fujio,

Nuclear Medicine and Biology

2006

20

Comparative assessments of crucial factors for a functional ligand-targeted nanocarrier

Md. Nazir Hossen, Kazuaki Kajimoto, Ryo Tatsumi,

Journal of drug targeting

2014

17

Page 1